Impact ofCOVID-19 on maintenance haemodialysis patients: The Indian scenario

被引:20
|
作者
Trivedi, Mayuri [1 ]
Shingada, Aakash [2 ]
Shah, Meera [1 ]
Khanna, Umesh [2 ]
Karnik, Niteen D. [1 ]
Ramachandran, Raja [3 ]
机构
[1] LTMG Hosp, Dept Med, Nephrol Serv, Mumbai 400022, Maharashtra, India
[2] Kidney Associates Pvt Ltd, Dept Nephrol, Mumbai, Maharashtra, India
[3] PGIMER, Dept Nephrol, Chandigarh, India
关键词
COVID-19; dialysis; renal replacement therapy; COVID-19; OUTCOMES;
D O I
10.1111/nep.13760
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
There is a lack of data describing the impact of the novel coronavirus 19 pandemic on the patients of chronic kidney disease stage V-dialysis (CKD V-D) from resource-limited countries. A growing body of literature describes an increased susceptibility of CKD V-D to COVID-19 with adverse outcomes in those with severe disease. In the current retrospective report, we elucidate the outcome in consecutive 37 CKD V-D patients with COVID-19 from two dialysis centres in Mumbai, India. Of the 37 patients included in the study, 56.7% of patients were asymptomatic or had mild disease and 27% presented with severe symptoms. The recovery rate was 63%, all those who presented with a severe disease succumbed to the infection. Thirty per cent of patients presented with an extended dialysis break due to various logistic and social issues. Though the overall clinical presentation and outcomes of this cohort from a limited resource setting mimic the global scenario, unique social and logistic issues are an additional burden to the patient, caregivers and the health-care facilities, which may worsen the outcomes in the future as the pandemic continues to spread.
引用
收藏
页码:929 / 932
页数:4
相关论文
共 50 条
  • [41] Provision ofCOVID-19 Convalescent Plasma in aResource-ConstrainedState
    Ipe, Tina S.
    Le, Tuan
    Quinn, Brian
    Kellar, Stan
    Clark, Melisa
    Carlisle, Suzanna
    Rassmann, Anja
    Hennigan, Steve
    Ridenour, Terry
    Roberts, Anthony
    Avery, David
    Ryan, Stefanie
    Pearson, Shanna
    Kothari, Atul
    Patil, Naveen
    [J]. TRANSFUSION, 2020, 60 (12) : 2828 - 2833
  • [42] Further evidence that chilblains are a cutaneous manifestation ofCOVID-19 infection
    Hughes, M.
    Rogers, S.
    Lepri, G.
    Bruni, C.
    Matucci-Cerinic, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (03) : 596 - 598
  • [43] Cancer and Risk ofCOVID-19 Through a General Community Survey
    Lee, Karla A.
    Ma, Wenjie
    Sikavi, Daniel R.
    Drew, David A.
    Nguyen, Long H.
    Bowyer, Ruth C. E.
    Cardoso, M. Jorge
    Fall, Tove
    Freidin, Maxim B.
    Gomez, Maria
    Graham, Mark
    Guo, Chuan-Guo
    Joshi, Amit D.
    Kwon, Sohee
    Lo, Chun-Han
    Lochlainn, Mary Ni
    Menni, Cristina
    Murray, Benjamin
    Mehta, Raaj
    Song, Mingyang
    Sudre, Carole H.
    Bataille, Veronique
    Varsavsky, Thomas
    Visconti, Alessia
    Franks, Paul W.
    Wolf, Jonathan
    Steves, Claire J.
    Ourselin, Sebastien
    Spector, Tim D.
    Chan, Andrew T.
    [J]. ONCOLOGIST, 2021, 26 (01): : E182 - E185
  • [44] Stemming the Tide ofCOVID-19 Infections in Massachusetts Nursing Homes
    Lipsitz, Lewis A.
    Lujan, Alida M.
    Dufour, Alyssa
    Abrahams, Gary
    Magliozzi, Helen
    Herndon, Laurie
    Dar, Mohammad
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (11) : 2447 - 2453
  • [45] Treatment ofCOVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
    Seirafianpour, Farnoosh
    Mozafarpoor, Samaneh
    Fattahi, Nima
    Sadeghzadeh-Bazargan, Afsaneh
    Hanifiha, Melika
    Goodarzi, Azadeh
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [46] Acute impact ofCOVID-19 pandemic on phenomenological features in fully or partially remitted patients with obsessive-compulsive disorder
    Matsunaga, Hisato
    Mukai, Keiichiro
    Yamanishi, Kyosuke
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020, 74 (10) : 565 - 566
  • [47] Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time ofCOVID-19 pandemic
    Infante, Marco
    Ricordi, Camillo
    Fabbri, Andrea
    [J]. JOURNAL OF DIABETES, 2020, 12 (09) : 659 - 667
  • [48] Safety measures in dermatology help minimize spread ofCOVID-19
    Goren, Andy
    Rathod, Dipali
    Kroumpouzos, George
    Jafferany, Mohammad
    Goldust, Mohamad
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [49] Global lockdown: An effective safeguard in responding to the threat ofCOVID-19
    Verma, Bhupendra Kumar
    Verma, Mamta
    Verma, Vikash Kumar
    Abdullah, Rifah B.
    Nath, Dilip C.
    Khan, Hafiz T. A.
    Verma, Anita
    Vishwakarma, Ramesh K.
    Verma, Vivek
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2020, 26 (06) : 1592 - 1598
  • [50] Factors leading to high morbidity and mortality ofCOVID-19 in patients with type 2 diabetes
    Rajpal, Aman
    Rahimi, Leili
    Ismail-Beigi, Faramarz
    [J]. JOURNAL OF DIABETES, 2020, 12 (12) : 895 - 908